Tel./Phone:  +49 201 43 70 97 0

 PakuMed Port GroßKatGW 5964 PakuMed Port Groß GW 5303 PakuMed Katheter GW 5785 PakuMed Umverpackung GW 5932 PakuMedSML03

 PakuMed Port GroßKatGW 5964 PakuMed Port Groß GW 5303 PakuMed Katheter GW 5785 PakuMed Umverpackung GW 5932 PakuMedSML03

Product description

TITAN-PORT Systems (Arterial/Venous) are fully implantable port systems consisting of an injection chamber (port) a screw closure mechanism, a self-sealing membrane, and a catheter. Each system includes a special puncture needle, this instruction guide, and a patient ID-card. Suitable introducer sets are available seperatly.

The port chamber consists of hypoallergenic biocompatible titanium. This material is non-magnetic. The base plate has openings for securing the system with sutures to the fascia. The port chamber and the catheter can be disconnected.

The silicone membrane can be punctured up to 3000 times with the enclosed non-coring special puncture needle. The membrane possesses a high-pressure stability and ensures proper positioning of the needle when placed.

The catheter (various models, sizes and materials depending on indication) can be shortened to the individual length required. It bears radiopaque calibration markings at 5 cm intervals, and is conically tapered at the tip. The arterial catheter has three distal fixation rings. The same applies to PU- (Polyurthane) Catheters.

Only special non-coring port-needles (SFN®-port needles recommended) should be used for puncture of the port membrane. These needles exhibit a unique bevel at the tip. This prevents punch defects of the membrane when the needle is advanced. (22 G or 20 G are recommended). Each system contains a suitable needle.

hochdruck gbAppropriate for Power Injection of contrast media via implanted Portcathetersystems


MR conditional

TITAN port catheter systems are MR-conditioned-safe. On request, we will be happy to provide you with further information.

Technical data

 Standard sets
 Art.Nr. Port Catheter PZN
  Material Base Height Septum Ø Weight Reservoir Material OD ID Lenght French  
hochdruck d111248 V (venous) 28 mm 13.5 mm 12 mm <16g 0.9 ml Silicone 2.5 mm 1.2 mm 700 mm 7.5 01673250
hochdruck d111248 V-PU (venous) Titanium 28 mm 13.5 mm 12 mm <16g 0.9 ml Polyurethane 2.5 mm 1.2 mm 720 mm 7.5 01673600

Suitable introducer sets are available separately.

Complete setS
 Art.Nr. Port Catheter PZN
  Material Base Height Septum Ø Weight Reservoir Material OD ID Length French  
hochdruck d111248 V-Set (venous)* Titanium 28 mm 13.5 mm 12 mm <16g 0.9 ml Silicone 2.5 mm 1.2 mm 700 mm 7.5 00200762
hochdruck d111248 V-PU-Set (venous)* Titanium 28 mm 13.5 mm 12 mm <16g 0.9 ml Polyurethane 2.5 mm 1.2 mm 720 mm 7.5 00201626
hochdruck d111257 V-PU-Set (venous)* Titanium 28 mm 13.5 mm 12 mm <16g 0.9 ml Polyurethane 3.0 mm 1.2 mm 700 mm 9.0 00205096

*includes introducer and tunnelizer.

hochdruck dAppropriate to high pressure radio-paque material injection - 300 psi/21 bar to 5,2 ml/sec
Power Injection of contrast media via implanted Portcathetersystems

Instruction for use

The TITAN-PORT Systems ensure repeated access to the vascular system for example for the following indications:

  • infusion therapy and long-term parenteral nutrition
  • systemic chemotherapy
  • administration of medications
  • regional chemotherapy
  • blood sampling, poor vascular situation
  • long-term infusion therapy and parenteral nutrition

In addition some systems may be used for following indications:

  • TITAN-PORT A (arterial): for direct perfusion of organs, for inoperable hepatic metastases via the gastroduodenal artery, via the coeliac trunk for pancreatic and via the aorta and internal iliac arteries for pelvic neoplasms
  • TITAN-PORT APH: for apheresis
  • TITAN-PORT AS/PT: for ascites- and peritoneal therapy
  • TITAN-PORT D: for dialysis (venous ↔ venous)
  • TITAN-PORT DR: for drainage
  • TITAN-PORT F: for fetal treatment
  • TITAN-PORT P: for pediatrics
  • TITAN-PORT UA: sideport

The TITAN-PORT systems should not be used in:

  • extremely rare cases of hypersensitivity to silicone, polyurethane or titanium
  • suspected bacteremia or sepsis
  • disseminated intravascular coagulation (DIC)

The following complications or adverse reactions can occur:

  • technical intraoperative complications
  • tissue incompatibility
  • local reactions (inflammation, edema, hematoma)
  • infection
  • disconnection or dislocation
  • thrombosis / thromboembolism
  • breakage of the catheter between the clavicle and first rib
  • breakage of catheter or damage to catheter
  • perforation of catheter
  • drug extravasation due to improper handling of the system
  • damage to neighboring tissues by the pharmaceutical agents (In the event of leakage of portal components)

Caution: During implantation sterile handling is absolutely mandatory!

  • various techniques are available for implantation of port and catheter, including the Seldinger technique
  • the choice depends on the surgeon's preference
  • the implantation of TITAN-PORT A/V is usually possible under local anesthesia
  • recommended sites for venous catheter placement include the cephalic vein, subclavian vein, or internal and external jugular veins.
  • use a 10 ml syringe and only special non-coring needles for puncturing the septum. The needles are intended for single use only.
  • the needle should be inserted into the silicon membrane carefully and always vertically to avoid bending the tip.
  • if the situation is unclear or thrombotic obstruction is suspected a radiographic or Doppler sonographic control is necessary.

To achieve greater flow rates the port membrane may be accessed simultaneously with up to three needles.

  • a venous implantation should be flushed with 20 ml 0,9% saline solution once every 3 months if the system is not used
  • for sampling venous blood 3 ml of blood schould initially be aspirated and discarded. A minimum 20 G needle should be used and the required amount of blood aspirated slowly (to avoid falsification of the results) * note: 18 G or 19 G needle is recommended for blood transfusion! Afterwards the system must be flushed immediately with at least 20-50 ml 0,9% saline solution. During the flushing procedure the needle may be rotated in different directions to ensure unifrom rinsing of the chamber interior
  • to avoid interactions between various drugs (cytostatic agents in particular) the system must be flushed with at least 10 ml 0,9% saline when repeated infusions are required
  • the system must be flushed after each use. The needle is removed with gentle force
  • when using needles with tube the lock schould be activated to avoid getting blood into the system
  • catheter obstruction due to thrombus formation can usually be cleared by injecting Streptokinase / Urokinase (e.g. 5000 IE/ml physiologic saline with 10 ml syringe, small amounts should be injected at intervals, allowed time to take effect and the patency checked)

(The above mentioned concentrations are recommendations and must always be adapted to patient's coagluation status as monitored by a physician. The product description of all pharmaceuticals used should always be consulted.)

  • the complication rate of thrombus formation in the catheter can be reduced in patients at risk by low-dose heparinization
  • in arterial portal systems, by the administration of a platelet aggregation inhibitor (e.g. acetylsalicylic acid).

CAUTION: High-pressure injections not unless patency of the system is confirmed by the physician (aspiration, manual
injection). In case of any doubt injection should be avoided!

Causes of abnormally high resistance to access needle may include

  • Incorrect placement of the access needle in the portal chamber
  • bending and kinking of the catheter
  • fibrin deposition or thrombotic occlusion of catheter or port.

Blood deposits in the system generally indicate one of the following causes:

  • leakage of the system
  • defective septum
  • faulty handling


  • the port can be removed under local anesthesia at the end of treatment (explantation is possible under local anesthesia)
  • irreversible obstruction of the portal system
  • breakage of catheter or damage to catheter
  • membrane leakage
  • poor patient compliance
  • massive thrombosis of the major vessels (subclavian vein, v.cava)
  • uncontrollable infection (port removal only under general anesthesia


  • the port should be secured to surrounding subcutaneous tissue by sutures or placed in the smallest of portal pockets in order to prevent port migration
  • the catheter must be secured to the vein with a firm, but not constricting suture
  • the proper connection of the catheter to the port must be confirmed


Meticulous hygiene and sterile handling technique are mandatory for the safe usage of TITAN-PORT Systems.This includes:

  • implantation in sterile setting
  • proper disinfection of hands and skin
  • sterile gloves when initiating treatment
  • use of sterile products


Regular treatment sessions and associated care of the port system are coincidental with monitoring of the port system.
Port systems should not be used by physicians / health care personnel not familiar with all aspects of the product and its potential complications. Complications can occur at any time during and after implantation.


Before each access the correct position of the portal chamber must be checked by palpation. Any signs of infection must be excluded. Without complications the TITAN-PORT Systems can be used one day after implantation.

Palpation Port


Introducer sets

Accessories for Seldinger Technique
Art.-Nr. Descrition PZN
ITS 432008 F Introducer 8 F, peel-away 02259794
ITS 432009 F Introducer 9 F, peel-away 02259848

info ports5 big PM-126 verlauf gr rl

PakuMed medical products © 2022